A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma
Cancer Reports · 2024
DOI: 10.1002/cnr2.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Lumeng Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Autophagy, Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Research, China, Shanghai Sailing Program, China.
Abstract (Originalsprache)
Background
In the era of immunotherapy, there is a critical need for effective biomarkers to improve outcome prediction and guide treatment decisions for patients with lung squamous cell carcinoma (LUSC). We hypothesized that the immune contexture of LUSC may be influenced by tumor intrinsic events, such as autophagy.
Aims
We aimed to develop an autophagy‐related risk signature and assess its predictive value for immune phenotype. Methods and Results Expression profiles of autophagy‐related genes (ARGs) in LUSC samples were obtained from the TCGA and GEO databases. Survival analyses were conducted to identify survival‐related ARGs and construct a risk signature using the Random Forest algorithm. Four ARGs (CFLAR, RGS19, PINK1, and CTSD) with the most significant prognostic value were selected to construct the risk signature. Patients in the high‐risk group exhibited worse prognosis than those in the low‐risk group ( p < 0.0001 in TCGA; p < 0.01 in GEO) and the risk score was identified as an independent prognostic factor. We observed that the high‐risk group displayed an immune‐suppressive status and showed higher levels of infiltrating regulatory T cells and macrophages, which are associated with poorer outcomes. Additionally, the risk score exhibited a significantly positive correlation with the expression of PD‐1 and CTLA4, as well as the estimate score and immune score.
Conclusion
This study provided an effective autophagy‐related prognostic signature, which could also predict the immune phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Zhejiang, China.
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Qiu Tang
Förderung
- National Natural Science Foundation of China Research, China
- Shanghai Sailing Program, China
Zitieren
APA
Luo, L., Deng, J., & Tang, Q. (2024). A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma. Cancer Reports. https://doi.org/10.1002/cnr2.70000
Vancouver
Luo L, Deng J, Tang Q. A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma. Cancer Reports. 2024. doi:10.1002/cnr2.70000
BibTeX
@article{Luo2024,
author = {Luo, Lumeng and Deng, Jiaying and Tang, Qiu},
title = {A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.70000}
}
EUVIMED